213 related articles for article (PubMed ID: 27982096)
1. A structural insight into the negative effects of opioids in analgesia by modulating the TLR4 signaling: An in silico approach.
Shah M; Anwar MA; Yesudhas D; Krishnan J; Choi S
Sci Rep; 2016 Dec; 6():39271. PubMed ID: 27982096
[TBL] [Abstract][Full Text] [Related]
2. Dissecting the innate immune recognition of morphine and its metabolites by TLR4/MD2: an
Zhang X; Li R; Xu H; Wu G; Wu S; Wang H; Wang Y; Wang X
Phys Chem Chem Phys; 2023 Nov; 25(43):29656-29663. PubMed ID: 37882236
[TBL] [Abstract][Full Text] [Related]
3. Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1beta.
Lewis SS; Hutchinson MR; Rezvani N; Loram LC; Zhang Y; Maier SF; Rice KC; Watkins LR
Neuroscience; 2010 Jan; 165(2):569-83. PubMed ID: 19833175
[TBL] [Abstract][Full Text] [Related]
4. Opioid activation of toll-like receptor 4 contributes to drug reinforcement.
Hutchinson MR; Northcutt AL; Hiranita T; Wang X; Lewis SS; Thomas J; van Steeg K; Kopajtic TA; Loram LC; Sfregola C; Galer E; Miles NE; Bland ST; Amat J; Rozeske RR; Maslanik T; Chapman TR; Strand KA; Fleshner M; Bachtell RK; Somogyi AA; Yin H; Katz JL; Rice KC; Maier SF; Watkins LR
J Neurosci; 2012 Aug; 32(33):11187-200. PubMed ID: 22895704
[TBL] [Abstract][Full Text] [Related]
5. Evidence that opioids may have toll-like receptor 4 and MD-2 effects.
Hutchinson MR; Zhang Y; Shridhar M; Evans JH; Buchanan MM; Zhao TX; Slivka PF; Coats BD; Rezvani N; Wieseler J; Hughes TS; Landgraf KE; Chan S; Fong S; Phipps S; Falke JJ; Leinwand LA; Maier SF; Yin H; Rice KC; Watkins LR
Brain Behav Immun; 2010 Jan; 24(1):83-95. PubMed ID: 19679181
[TBL] [Abstract][Full Text] [Related]
6. Dissecting the Innate Immune Recognition of Opioid Inactive Isomer (+)-Naltrexone Derived Toll-like Receptor 4 (TLR4) Antagonists.
Zhang X; Cui F; Chen H; Zhang T; Yang K; Wang Y; Jiang Z; Rice KC; Watkins LR; Hutchinson MR; Li Y; Peng Y; Wang X
J Chem Inf Model; 2018 Apr; 58(4):816-825. PubMed ID: 29518316
[TBL] [Abstract][Full Text] [Related]
7. Evidence that tricyclic small molecules may possess toll-like receptor and myeloid differentiation protein 2 activity.
Hutchinson MR; Loram LC; Zhang Y; Shridhar M; Rezvani N; Berkelhammer D; Phipps S; Foster PS; Landgraf K; Falke JJ; Rice KC; Maier SF; Yin H; Watkins LR
Neuroscience; 2010 Jun; 168(2):551-63. PubMed ID: 20381591
[TBL] [Abstract][Full Text] [Related]
8. Comparison of (+)- and (-)-Naloxone on the Acute Psychomotor-Stimulating Effects of Heroin, 6-Acetylmorphine, and Morphine in Mice.
Eriksen GS; Andersen JM; Boix F; Bergh MS; Vindenes V; Rice KC; Huestis MA; Mørland J
J Pharmacol Exp Ther; 2016 Aug; 358(2):209-15. PubMed ID: 27278234
[TBL] [Abstract][Full Text] [Related]
9. Sex-dependent influences of morphine and its metabolites on pain sensitivity in the rat.
Doyle HH; Murphy AZ
Physiol Behav; 2018 Apr; 187():32-41. PubMed ID: 29199028
[TBL] [Abstract][Full Text] [Related]
10. Lipid A from lipopolysaccharide recognition: structure, dynamics and cooperativity by molecular dynamics simulations.
Garate JA; Oostenbrink C
Proteins; 2013 Apr; 81(4):658-74. PubMed ID: 23184816
[TBL] [Abstract][Full Text] [Related]
11. Activation of adult rat CNS endothelial cells by opioid-induced toll-like receptor 4 (TLR4) signaling induces proinflammatory, biochemical, morphological, and behavioral sequelae.
Grace PM; Ramos KM; Rodgers KM; Wang X; Hutchinson MR; Lewis MT; Morgan KN; Kroll JL; Taylor FR; Strand KA; Zhang Y; Berkelhammer D; Huey MG; Greene LI; Cochran TA; Yin H; Barth DS; Johnson KW; Rice KC; Maier SF; Watkins LR
Neuroscience; 2014 Nov; 280():299-317. PubMed ID: 25241065
[TBL] [Abstract][Full Text] [Related]
12. Role of Nociceptor Toll-like Receptor 4 (TLR4) in Opioid-Induced Hyperalgesia and Hyperalgesic Priming.
Araldi D; Bogen O; Green PG; Levine JD
J Neurosci; 2019 Aug; 39(33):6414-6424. PubMed ID: 31209174
[TBL] [Abstract][Full Text] [Related]
13. Toll-Like Receptor 4 (TLR4)/Opioid Receptor Pathway Crosstalk and Impact on Opioid Analgesia, Immune Function, and Gastrointestinal Motility.
Zhang P; Yang M; Chen C; Liu L; Wei X; Zeng S
Front Immunol; 2020; 11():1455. PubMed ID: 32733481
[TBL] [Abstract][Full Text] [Related]
14. Morphine decreases the function of primary human natural killer cells by both TLR4 and opioid receptor signaling.
Maher DP; Walia D; Heller NM
Brain Behav Immun; 2020 Jan; 83():298-302. PubMed ID: 31626971
[TBL] [Abstract][Full Text] [Related]
15. Activation of μ-opioid receptor and Toll-like receptor 4 by plasma from morphine-treated mice.
Xie N; Gomes FP; Deora V; Gregory K; Vithanage T; Nassar ZD; Cabot PJ; Sturgess D; Shaw PN; Parat MO
Brain Behav Immun; 2017 Mar; 61():244-258. PubMed ID: 27939249
[TBL] [Abstract][Full Text] [Related]
16. Morphine activates neuroinflammation in a manner parallel to endotoxin.
Wang X; Loram LC; Ramos K; de Jesus AJ; Thomas J; Cheng K; Reddy A; Somogyi AA; Hutchinson MR; Watkins LR; Yin H
Proc Natl Acad Sci U S A; 2012 Apr; 109(16):6325-30. PubMed ID: 22474354
[TBL] [Abstract][Full Text] [Related]
17. Toll-like receptors change morphine-induced antinociception, tolerance and dependence: Studies using male and female TLR and signalling gene KO mice.
Thomas JHL; Lui L; Abell A; Tieu W; Somogyi AA; Bajic JE; Hutchinson MR
Brain Behav Immun; 2022 May; 102():71-85. PubMed ID: 35131445
[TBL] [Abstract][Full Text] [Related]
18. MD2 mediates angiotensin II-induced cardiac inflammation and remodeling via directly binding to Ang II and activating TLR4/NF-κB signaling pathway.
Han J; Zou C; Mei L; Zhang Y; Qian Y; You S; Pan Y; Xu Z; Bai B; Huang W; Liang G
Basic Res Cardiol; 2017 Jan; 112(1):9. PubMed ID: 28013347
[TBL] [Abstract][Full Text] [Related]
19. Unveiling the Interplay between the TLR4/MD2 Complex and HSP70 in the Human Cardiovascular System: A Computational Approach.
de Oliveira AA; Faustino J; de Lima ME; Menezes R; Nunes KP
Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31247943
[TBL] [Abstract][Full Text] [Related]
20. Sulforaphane inhibits the engagement of LPS with TLR4/MD2 complex by preferential binding to Cys133 in MD2.
Koo JE; Park ZY; Kim ND; Lee JY
Biochem Biophys Res Commun; 2013 May; 434(3):600-5. PubMed ID: 23583403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
